Today we are happy to welcome Edward van Wezel, Founding and Managing Partner of BioGeneration Ventures. Launched in 2006, BGV has managed over 250 million euros across four funds. They invest in medical and healthcare innovations that have high potential to positively impact patients.
In this episode you’ll learn:
Edward’s route from chemical engineering to VC
How BGV thinks about sourcing from all of Europe and why certain geos have risen to be their core focus
On working with universities, research institutes, TTOs and the status of IP ownership in Europe
On building your ideal LP base and the importance of designing for diversity
You can also listen on your favorite podcast platforms: linktree.com/theeuropeanvc